Paper Details

Paper Title

LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer.

Paper Journal Title

Cancer Res

Paper Citation Count

120

Paper Publication Year

2010

Bio Mention

Mesh Descriptor

Column Actions